Home / Certara Pharmacometrics Services Consultation

Pharmacometrics
Services

Power Confident Drug Development with Expert Pharmacometrics Support

Facing high-stakes development decisions or regulatory pressure? Certara’s expert pharmacometric consulting helps reduce risk, streamline trials, and accelerate approvals. As the world’s largest and most experienced pharmacometrics consulting team, we’ve supported over 600 programs across all phases of development. Trusted by global sponsors and regulators alike, our deep expertise spans PK/PD, PopPK, PBPK, MBMA, QSP, and more—delivering data-driven insights that drive confident decisions.

Smarter Decisions. Faster Submissions. Greater Confidence.

Our global team of 120+ pharmacometricians delivers strategic, data-driven solutions to:

De-risk development and inform go/no-go decisions
Optimize dose selection and trial design
Accelerate submission readiness
Maximize regulatory and clinical success

What We Offer:

Strategic pharmacometric consulting and decision support
PK/PD, PopPK, and exposure–response modeling
Model-Based Meta-Analysis (MBMA) for payer and competitor insights
Pediatric extrapolation and simulations in virtual populations
Regulatory-aligned modeling to support global submissions

Real-World Impact. Measurable Results. Certainty starts here.

"Partnering with Certara’s pharmacometrics team was a game changer for our development program. Their modeling expertise gave us the clarity and confidence we needed to select the optimal dose and design a streamlined clinical strategy. Thanks to their support, we avoided an additional Phase 2 trial and accelerated our regulatory submission timeline."

— VP, Clinical Development, Mid-Size Biotech Company

schedule a consultation

About Certara

Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.

From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.